1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 20 JULY 2015

Cancer Drug News 20 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Immunocore's Future Looks Bright
Industry Trend Analysis - Positive Phase II Blincyto Data Will Secure Second FDA Nod
Industry Brief - Celator Begins CPX-351 Phase II Trial In AML Patients At High Risk For Induction Mortality
Industry Trend Analysis - Ixazomib Will Gain Swift Approval In US
Industry Brief - Cleave's CB-5083 Gains FDA ODD For MM
Industry Brief - Argos Completes Enrolment In AGS-003 Phase III Trial In MRCC
Industry Trend Analysis - Exelixis Will Finally See Success With Cabozantinib
Industry Brief - Cellceutix' Kevetrin Gains FDA ODD For OC
Industry Brief - Immunovaccine's DPX-Survivac Gains FDA ODD For OC
Industry Brief - DSMB Recommends Continuation Per Protocol Of Genticel's GTL001 Phase II Trial
Industry Trend Analysis - EMA's HPV Vaccine Safety Review Will Have Little Impact On Sales
Industry Brief - Delcath Receives FDA ODD For Melphalan In Cholangiocarcinoma
Industry Brief - Kowa/Chugai Sign Japanese Peretinoin Licensing Deal For HCC
Industry Brief - Apogenix/CANbridge Sign APG101 Licensing Deal In China
Industry Brief - RedHill Extends Option Agreement For RP101 Acquisition
Industry Brief - Agenus Acquires CEACAM1 Antibodies From Diatheva
Industry Brief - Hikma Gains US Thiotepa sANDA Approval
Industry Brief - Sanofi To Reorganise Business Structure
Industry Brief - Sorrento/NantBioScience Form JV To Develop Small Molecule Therapies Against Cancer
Industry Brief - Cancer Conferences - October 2015

Table Of Contents

Cancer Drug News 20 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.